Paper20157080
Predictors of occult nodal metastasis in patients with thin melanoma.
Faries MB and 4 others. Arch Surg, 2010. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Predictors of occult nodal metastasis in patients with thin melanoma. Papers, record 20157080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20157080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymph Node Excision | Major topic |
| Melanoma | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Skin Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Child | |
| Cohort Studies | |
| Databases, Factual | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Risk Factors | |
| Sex Factors | |
| Survival Analysis | |
| Young Adult |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA029605 | NCI NIH HHS | United States | P01CA029605 | PubMed and NIH | NIH RePORTER |
| CA12582 | NCI NIH HHS | United States | P01CA012582 | PubMed and NIH | NIH RePORTER |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14605613 | Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. | Surgery | 2003 | https://conductscience.org/library/papers/14605613 | PubMed |
| 2 | 14530724 | Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. | Ann Surg | 2003 | https://conductscience.org/library/papers/14530724 | PubMed |
| 3 | 17005948 | Sentinel-node biopsy or nodal observation in melanoma. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17005948 | PubMed |
| 4 | 3942987 | Recurrence potential of thin primary melanomas. | Cancer | 1986 | https://conductscience.org/library/papers/3942987 | PubMed |
| 5 | 16258494 | Sentinel node biopsy for thin melanomas: which patients should be considered? | Cancer Control | 2005 | https://conductscience.org/library/papers/16258494 | PubMed |
| 6 | 16418885 | American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. | Ann Surg Oncol | 2006 | https://conductscience.org/library/papers/16418885 | PubMed |
| 7 | 15383424 | Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm). | Ann Surg Oncol | 2004 | https://conductscience.org/library/papers/15383424 | PubMed |
| 8 | 14530725 | Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. | Ann Surg | 2003 | https://conductscience.org/library/papers/14530725 | PubMed |
| 9 | 12663722 | Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12663722 | PubMed |
| 10 | 11251950 | Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. | Cancer | 2001 | https://conductscience.org/library/papers/11251950 | PubMed |
| 11 | 16523360 | Predictors of regional nodal disease in patients with thin melanomas. | Ann Surg Oncol | 2006 | https://conductscience.org/library/papers/16523360 | PubMed |
| 12 | 14993019 | Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. | Ann Surg Oncol | 2004 | https://conductscience.org/library/papers/14993019 | PubMed |
| 13 | 10894142 | Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. | Ann Surg Oncol | 2000 | https://conductscience.org/library/papers/10894142 | PubMed |
| 14 | 16258103 | Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16258103 | PubMed |
| 15 | 15864482 | Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. | Ann Surg Oncol | 2005 | https://conductscience.org/library/papers/15864482 | PubMed |
| 16 | 17146784 | The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. | Cancer | 2007 | https://conductscience.org/library/papers/17146784 | PubMed |
| 17 | 18794428 | Importance of sentinel lymph node biopsy in patients with thin melanoma. | Arch Surg | 2008 | https://conductscience.org/library/papers/18794428 | PubMed |
| 18 | 12640499 | Vertical growth phase and positive sentinel node in thin melanoma. | Braz J Med Biol Res | 2003 | https://conductscience.org/library/papers/12640499 | PubMed |
| 19 | 10819365 | Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. | Ann Surg Oncol | 2000 | https://conductscience.org/library/papers/10819365 | PubMed |
| 20 | 10091790 | Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression. | Cancer | 1999 | https://conductscience.org/library/papers/10091790 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588673 | Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588673 | PubMed |
| 40900446 | A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma. | J Eur Acad Dermatol Venereol | 2026 | https://conductscience.org/library/papers/40900446 | PubMed |
| 39518065 | Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39518065 | PubMed |
| 36259947 | Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma. | Cancer Discov | 2023 | https://conductscience.org/library/papers/36259947 | PubMed |
| 36159108 | Dermoscopy for Cutaneous Melanoma: Under the Eye of Both the Dermatologist and the Legal Doctor. | Dermatol Pract Concept | 2022 | https://conductscience.org/library/papers/36159108 | PubMed |
| 32167862 | Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/32167862 | PubMed |
| 31260100 | Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31260100 | PubMed |
| 30181807 | Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile. | Oncotarget | 2018 | https://conductscience.org/library/papers/30181807 | PubMed |
| 29641692 | Prognostic factors for metastasis in cutaneous melanoma. | An Bras Dermatol | 2018 | https://conductscience.org/library/papers/29641692 | PubMed |
| 27807729 | Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis. | Ann Surg Oncol | 2017 | https://conductscience.org/library/papers/27807729 | PubMed |
| 27671840 | Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy. | Cancer Med | 2016 | https://conductscience.org/library/papers/27671840 | PubMed |
| 24610543 | Thin melanoma and late recurrences: it is never too thin and never too late. | Med Oncol | 2014 | https://conductscience.org/library/papers/24610543 | PubMed |
| 24369020 | Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/24369020 | PubMed |
| 22766986 | Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22766986 | PubMed |
| 22469345 | Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. | Mayo Clin Proc | 2012 | https://conductscience.org/library/papers/22469345 | PubMed |
| 20512942 | Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. | J Surg Oncol | 2010 | https://conductscience.org/library/papers/20512942 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20157080
GET https://conductscience.org/api/papers/v1/20157080/references?page=2